Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oramed Pharm (ORMP) just unveiled an update.
Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Avraham Gabay as the new Chief Financial Officer, Treasurer, and Secretary, set to begin on June 18, 2024. Gabay brings a wealth of experience, having previously held financial leadership roles at BiomX Inc., Oravax Inc., and other notable firms. He is also a certified public accountant and a member of the Israeli Bar Association. His compensation includes a monthly salary, bonuses, equity grants, and a company car, all determined by the company’s Board of Directors and Compensation Committee.
For a thorough assessment of ORMP stock, go to TipRanks’ Stock Analysis page.